ANRO - Alto Neuroscience Inc. -  [ ]

Ticker Details
Alto Neuroscience Inc.
IPO Date: February 2, 2024
Sector: Healthcare
Industry: Biotech
Market Cap: $547.39M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.38 | 4.26%
Avg Daily Range (30 D): $0.69 | 4.13%
Avg Daily Range (90 D): $0.70 | 5.20%
Institutional Daily Volume
Avg Daily Volume: .44M
Avg Daily Volume (30 D): .18M
Avg Daily Volume (90 D): .52M
Trade Size
Avg Trade Size (Sh.): 110
Avg Trade Size (Sh.) (30 D): 58
Avg Trade Size (Sh.) (90 D): 88
Institutional Trades
Total Institutional Trades: 89
Avg Institutional Trade: $1.6M
Avg Institutional Trade (30 D): $.55M
Avg Institutional Trade (90 D): $1.53M
Avg Institutional Trade Volume: .15M
Avg Institutional Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $3.24M
Avg Closing Trade (30 D): $11.9M
Avg Closing Trade (90 D): $3.59M
Avg Closing Volume: 300.19K
 
News
Oct 7, 2025 @ 10:05 PM
ALTO ALERT: Bragar Eagel & Squire, P.C. is Investi...
Source: Bragar Eagel & Squire, P.C.
Sep 19, 2025 @ 8:49 PM
Investors who lost money on Alto Neuroscience, Inc...
Source: Levi & Korsinsky, Llp
Sep 19, 2025 @ 1:50 PM
ANRO DEADLINE TODAY: ROSEN, A HIGHLY RECOGNIZED LA...
Source: Rosen Law Firm
Sep 18, 2025 @ 8:00 PM
ANRO INVESTOR ALERT: Bronstein, Gewirtz & Grossman...
Source: Bronstein, Gewirtz & Grossman Llc
Sep 18, 2025 @ 3:40 AM
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates ...
Source: James (Josh) Wilson
Financials
  TTM Q3 2025 Q2 2025
Basic EPS $-2.3 $-.52
Diluted EPS $-2.3 $-.52
Revenue $M $M
Gross Profit
Net Income / Loss $-62.26M $-14.18M $-17.71M
Operating Income / Loss $-66.31M $-14.95M
Cost of Revenue
Net Cash Flow $-43.89M
PE Ratio